QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARESQUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARESQUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES

QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES

No trades
See on Supercharts

QNTM fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

QNTM does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company